Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems

Colin Longstaff, John Hogwood, Elaine Gray, Erzsébet Komorowicz, Imre Varjú, Z. Varga, K. Kolev

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Neutrophil extracellular traps (NETs) composed primarily of DNA and histones are a link between infection, inflammation and coagulation. NETs promote coagulation and approaches to destabilise NETs have been explored to reduce thrombosis and treat sepsis. Heparinoids bind histones and we report quantitative studies in plasma and purified systems to better understand physiological consequences. Unfraction-ated heparin (UFH) was investigated by activated partial thromboplas­tin time (APTT) and alongside low-molecular-weight heparins (LMWH) in purified systems with thrombin or factor Xa (FXa) and antithrombin (AT) to measure the sensitivity of UFH or LMWH to histones. A method was developed to assess the effectiveness of DNA and non-anticoagu­lant heparinoids as anti-histones. Histones effectively neutralised UFH, the IC50 value for neutralisation of 0.2 lU/ml UFH was 1.8 |jg/ml hi­stones in APTT and 4.6 |jg/ml against 0.6 lU/ml UFH in a purified sys­tem. Histones also inhibited the activities of LMWHs with thrombin (IC50 6.1 and 11.0 |jg/ml histones, for different LMWHs) or FXa (IC50 7.8 and 7.0 |jg/ml histones). Direct interactions of UFH and LMWH with DNA and histones were explored by surface plasmon resonance, while rheology studies showed complex effects of histones, UFH and LMWH on clot resilience. A conclusion from these studies is that anti-coagulation by UFH and LMWH will be compromised by high affinity binding to circulating histones even in the presence of DNA. A com­plete understanding of the effects of histones, DNA and heparins on the haemostatic system must include an appreciation of direct effects on fibrin and clot structure.

Original languageEnglish
Pages (from-to)591-599
Number of pages9
JournalThrombosis and Haemostasis
Volume115
Issue number3
DOIs
Publication statusPublished - 2016

Fingerprint

Coagulants
Histones
Heparin
Low Molecular Weight Heparin
Heparinoids
DNA
Inhibitory Concentration 50
Factor Xa
Partial Thromboplastin Time
Thrombin
Antithrombins
Surface Plasmon Resonance
Rheology
Hemostatics
Fibrin
Sepsis

Keywords

  • APTT
  • DNA
  • Heparin
  • Histones
  • Neutrophil extracellular traps

ASJC Scopus subject areas

  • Hematology

Cite this

Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems. / Longstaff, Colin; Hogwood, John; Gray, Elaine; Komorowicz, Erzsébet; Varjú, Imre; Varga, Z.; Kolev, K.

In: Thrombosis and Haemostasis, Vol. 115, No. 3, 2016, p. 591-599.

Research output: Contribution to journalArticle

Longstaff, Colin ; Hogwood, John ; Gray, Elaine ; Komorowicz, Erzsébet ; Varjú, Imre ; Varga, Z. ; Kolev, K. / Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems. In: Thrombosis and Haemostasis. 2016 ; Vol. 115, No. 3. pp. 591-599.
@article{bb3d130eaca14b16a407e37359abbac0,
title = "Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems",
abstract = "Neutrophil extracellular traps (NETs) composed primarily of DNA and histones are a link between infection, inflammation and coagulation. NETs promote coagulation and approaches to destabilise NETs have been explored to reduce thrombosis and treat sepsis. Heparinoids bind histones and we report quantitative studies in plasma and purified systems to better understand physiological consequences. Unfraction-ated heparin (UFH) was investigated by activated partial thromboplas­tin time (APTT) and alongside low-molecular-weight heparins (LMWH) in purified systems with thrombin or factor Xa (FXa) and antithrombin (AT) to measure the sensitivity of UFH or LMWH to histones. A method was developed to assess the effectiveness of DNA and non-anticoagu­lant heparinoids as anti-histones. Histones effectively neutralised UFH, the IC50 value for neutralisation of 0.2 lU/ml UFH was 1.8 |jg/ml hi­stones in APTT and 4.6 |jg/ml against 0.6 lU/ml UFH in a purified sys­tem. Histones also inhibited the activities of LMWHs with thrombin (IC50 6.1 and 11.0 |jg/ml histones, for different LMWHs) or FXa (IC50 7.8 and 7.0 |jg/ml histones). Direct interactions of UFH and LMWH with DNA and histones were explored by surface plasmon resonance, while rheology studies showed complex effects of histones, UFH and LMWH on clot resilience. A conclusion from these studies is that anti-coagulation by UFH and LMWH will be compromised by high affinity binding to circulating histones even in the presence of DNA. A com­plete understanding of the effects of histones, DNA and heparins on the haemostatic system must include an appreciation of direct effects on fibrin and clot structure.",
keywords = "APTT, DNA, Heparin, Histones, Neutrophil extracellular traps",
author = "Colin Longstaff and John Hogwood and Elaine Gray and Erzs{\'e}bet Komorowicz and Imre Varj{\'u} and Z. Varga and K. Kolev",
year = "2016",
doi = "10.1160/TH15-03-0214",
language = "English",
volume = "115",
pages = "591--599",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "3",

}

TY - JOUR

T1 - Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems

AU - Longstaff, Colin

AU - Hogwood, John

AU - Gray, Elaine

AU - Komorowicz, Erzsébet

AU - Varjú, Imre

AU - Varga, Z.

AU - Kolev, K.

PY - 2016

Y1 - 2016

N2 - Neutrophil extracellular traps (NETs) composed primarily of DNA and histones are a link between infection, inflammation and coagulation. NETs promote coagulation and approaches to destabilise NETs have been explored to reduce thrombosis and treat sepsis. Heparinoids bind histones and we report quantitative studies in plasma and purified systems to better understand physiological consequences. Unfraction-ated heparin (UFH) was investigated by activated partial thromboplas­tin time (APTT) and alongside low-molecular-weight heparins (LMWH) in purified systems with thrombin or factor Xa (FXa) and antithrombin (AT) to measure the sensitivity of UFH or LMWH to histones. A method was developed to assess the effectiveness of DNA and non-anticoagu­lant heparinoids as anti-histones. Histones effectively neutralised UFH, the IC50 value for neutralisation of 0.2 lU/ml UFH was 1.8 |jg/ml hi­stones in APTT and 4.6 |jg/ml against 0.6 lU/ml UFH in a purified sys­tem. Histones also inhibited the activities of LMWHs with thrombin (IC50 6.1 and 11.0 |jg/ml histones, for different LMWHs) or FXa (IC50 7.8 and 7.0 |jg/ml histones). Direct interactions of UFH and LMWH with DNA and histones were explored by surface plasmon resonance, while rheology studies showed complex effects of histones, UFH and LMWH on clot resilience. A conclusion from these studies is that anti-coagulation by UFH and LMWH will be compromised by high affinity binding to circulating histones even in the presence of DNA. A com­plete understanding of the effects of histones, DNA and heparins on the haemostatic system must include an appreciation of direct effects on fibrin and clot structure.

AB - Neutrophil extracellular traps (NETs) composed primarily of DNA and histones are a link between infection, inflammation and coagulation. NETs promote coagulation and approaches to destabilise NETs have been explored to reduce thrombosis and treat sepsis. Heparinoids bind histones and we report quantitative studies in plasma and purified systems to better understand physiological consequences. Unfraction-ated heparin (UFH) was investigated by activated partial thromboplas­tin time (APTT) and alongside low-molecular-weight heparins (LMWH) in purified systems with thrombin or factor Xa (FXa) and antithrombin (AT) to measure the sensitivity of UFH or LMWH to histones. A method was developed to assess the effectiveness of DNA and non-anticoagu­lant heparinoids as anti-histones. Histones effectively neutralised UFH, the IC50 value for neutralisation of 0.2 lU/ml UFH was 1.8 |jg/ml hi­stones in APTT and 4.6 |jg/ml against 0.6 lU/ml UFH in a purified sys­tem. Histones also inhibited the activities of LMWHs with thrombin (IC50 6.1 and 11.0 |jg/ml histones, for different LMWHs) or FXa (IC50 7.8 and 7.0 |jg/ml histones). Direct interactions of UFH and LMWH with DNA and histones were explored by surface plasmon resonance, while rheology studies showed complex effects of histones, UFH and LMWH on clot resilience. A conclusion from these studies is that anti-coagulation by UFH and LMWH will be compromised by high affinity binding to circulating histones even in the presence of DNA. A com­plete understanding of the effects of histones, DNA and heparins on the haemostatic system must include an appreciation of direct effects on fibrin and clot structure.

KW - APTT

KW - DNA

KW - Heparin

KW - Histones

KW - Neutrophil extracellular traps

UR - http://www.scopus.com/inward/record.url?scp=84959520425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959520425&partnerID=8YFLogxK

U2 - 10.1160/TH15-03-0214

DO - 10.1160/TH15-03-0214

M3 - Article

C2 - 26632486

AN - SCOPUS:84959520425

VL - 115

SP - 591

EP - 599

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 3

ER -